Nick Merryfield LLP (NMLLP), a private equity firm focused on the healthcare industry, has announced the formation of a pioneering market access organisation, the Verpora Group.
Under an international agreement, the Verpora Group will help improve patient access to life-enhancing medicines through the integration of three specialised businesses.
In the first deal, NMLLP has taken a 50% stake in White Space Analytics Ltd. (WSA), a data intelligence company with extensive experience in improving patient outcomes using predictive analytics and record-level data analysis.
Nick Merryfield, Managing Partner of NMLLP and Chief Executive of the Verpora Group, said: “We are delighted White Space Analytics will be helping spearhead the Verpora Group at a time of phenomenal growth for the organisation. The business has a wealth of expertise in employing leading-edge data intelligence to help payers, providers, and pharmaceutical companies achieve improved patient access to life-enhancing technologies.”
Adam Meads, Founder of WSA, said: “It is an exceptional opportunity to become a major part of the Verpora Group and help lead the company’s global expansion. Data intelligence is now fundamental to ensuring the right patients, receive the right medicine, at the right time. I am extremely excited by the vision we offer our clients.”
In separate agreements, the healthcare investor announced that it will also bring Stisali Ltd. and WorldDataOnline LLC into the Verpora Group.